ISS Seen Weighing in on Celgene (CELG)/Bristol-Myers Squibb (BMY) Deal on Monday - Faber
Proxy advisory service ISS is expected to weigh in on the Bristol-Myers Squibb (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)